JBM (Healthcare) Limited

SEHK:2161 Stock Report

Market Cap: HK$839.2m

JBM (Healthcare) Past Earnings Performance

Past criteria checks 5/6

JBM (Healthcare) has been growing earnings at an average annual rate of 32.3%, while the Pharmaceuticals industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 14.5% per year. JBM (Healthcare)'s return on equity is 13.4%, and it has net margins of 20.1%.

Key information

32.3%

Earnings growth rate

48.3%

EPS growth rate

Pharmaceuticals Industry Growth5.6%
Revenue growth rate14.5%
Return on equity13.4%
Net Margin20.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Recent updates

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

Nov 01
Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Jul 29
JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Aug 03
Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Jul 28
Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Revenue & Expenses Breakdown

How JBM (Healthcare) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2161 Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 246481301800
31 Dec 236291141750
30 Sep 23610981700
30 Jun 23565781540
31 Mar 23520571380
31 Dec 22487471300
30 Sep 22454361220
30 Jun 22430301220
31 Mar 22406251230
31 Dec 21398181240
30 Sep 21390111260
30 Jun 21394171270
31 Mar 21397231280
31 Mar 20382411390
31 Mar 19308521070
31 Mar 1826442950

Quality Earnings: 2161 has high quality earnings.

Growing Profit Margin: 2161's current net profit margins (20.1%) are higher than last year (11%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2161's earnings have grown significantly by 32.3% per year over the past 5 years.

Accelerating Growth: 2161's earnings growth over the past year (128.5%) exceeds its 5-year average (32.3% per year).

Earnings vs Industry: 2161 earnings growth over the past year (128.5%) exceeded the Pharmaceuticals industry -5%.


Return on Equity

High ROE: 2161's Return on Equity (13.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.